The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate Alzheimer’s disease under the federal agency’s expanded access ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

The use of mouse models in this research has provided critical insights into the nasal spray’s effectiveness. These preclinical trials revealed not only a reduction in neuroinflammatory markers ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression ... full remission from their symptoms after using one antidepressant medication, and 50% have ...

When a cold leaves you stuffed up, you can get fast relief from a nasal spray. But take a minute to learn the different types and how to use them. It can make all the difference in effectively ...